BRISTOL-MYERS SQUIBB COMPANY Proceeds from Divestiture of Businesses
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Proceeds from Divestiture of Businesses of $364.00 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-10-25.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinesses · last filed 2018-10-25
- BRISTOL-MYERS SQUIBB COMPANY proceeds from divestiture of businesses for the quarter ending 2018-09-30 was $364.00M, a 165.69% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY proceeds from divestiture of businesses for the quarter ending 2018-06-30 was $208.00M, a 40.54% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY proceeds from divestiture of businesses for the quarter ending 2018-03-31 was $375.00M, a 55.60% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY proceeds from divestiture of businesses for the quarter ending 2017-09-30 was $137.00M.
- BRISTOL-MYERS SQUIBB COMPANY proceeds from divestiture of businesses for fiscal 2009 was $0.00, a 100.00% decline from fiscal 2008.
- BRISTOL-MYERS SQUIBB COMPANY proceeds from divestiture of businesses for fiscal 2008 was $4.53B.
- BRISTOL-MYERS SQUIBB COMPANY proceeds from divestiture of businesses for fiscal 2007 was $0.00.
| Period end | Proceeds from Divestiture of Businesses 3 month | Proceeds from Divestiture of Businesses 6 month | Proceeds from Divestiture of Businesses 9 month | Proceeds from Divestiture of Businesses 12 month |
|---|---|---|---|---|
| 2018-09-30 | $364.00M 10-Q · filed 2018-10-25 | $572.00M derived: sum of 2 quarters · filed 2018-10-25 | $947.00M 10-Q · filed 2018-10-25 | |
| 2018-06-30 | $208.00M 10-Q · filed 2018-07-26 | $583.00M 10-Q · filed 2018-07-26 | ||
| 2018-03-31 | $375.00M 10-Q · filed 2018-04-26 | |||
| 2017-09-30 | $137.00M 10-Q · filed 2018-10-25 | $285.00M derived: sum of 2 quarters · filed 2018-10-25 | $526.00M 10-Q · filed 2018-10-25 | |
| 2017-06-30 | $148.00M 10-Q · filed 2018-07-26 | $389.00M 10-Q · filed 2018-07-26 | ||
| 2017-03-31 | $241.00M 10-Q · filed 2018-04-26 | |||
| 2016-03-31 | $350.00M 10-Q · filed 2016-04-28 | |||
| 2015-09-30 | $121.00M 10-Q · filed 2015-10-27 | |||
| 2009-12-31 | -$85.00M derived: 10-K 12 month − 10-Q 9 month · filed 2010-02-19 | -$68.00M derived: sum of 2 quarters · filed 2010-02-19 | $0.00 10-K · filed 2010-02-19 | |
| 2009-09-30 | $17.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-22 | $85.00M 10-Q · filed 2009-10-22 | ||
| 2009-06-30 | $68.00M 10-Q · filed 2009-07-23 | |||
| 2008-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $4.05B derived: sum of 2 quarters · filed 2011-02-18 | $4.53B 10-K · filed 2011-02-18 | |
| 2008-09-30 | $4.05B derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-22 | $4.53B 10-Q · filed 2009-10-22 | ||
| 2008-06-30 | $483.00M 10-Q · filed 2009-07-23 | |||
| 2007-12-31 | $0.00 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |